Oligodendroglial maldevelopment in the cerebellum after postnatal hyperoxia and its prevention by minocycline

Till Scheuer1,2, Vivien Brockmöller1, Marissa Blanco Knowlton3

  • 1Department for Neonatology, Charité University Medical Center, Berlin, Germany.

Glia
|May 13, 2015
PubMed

Insights

Postnatal hyperoxia (high oxygen) injures the cerebellum in newborn rats, impairing white matter development. Minocycline treatment protected against this brain injury, offering a potential therapeutic strategy for premature infants.

Area of Science:

  • Neuroscience
  • Developmental Biology
  • Neonatal Research

Background:

  • Brain injury, particularly in the cerebellum, is a significant concern following premature birth.
  • The precise causes of cerebellar injury in premature infants remain poorly understood.
  • Postnatal hyperoxia is a common clinical condition in premature infants that may contribute to brain injury.

Purpose of the Study:

  • To investigate if postnatal hyperoxia affects cerebellar white matter development in neonatal rats.
  • To determine if minocycline can prevent glial damage and white matter injury in the cerebellum caused by hyperoxia.

Main Methods:

  • Neonatal rats were exposed to hyperoxia (80% O2) for 24 hours, with or without minocycline treatment.
  • Cerebellar tissues were analyzed for oxidative stress, oligodendrocyte development, myelination markers, and growth factors.
  • Magnetic Resonance Imaging (MRI) was used to assess cerebellar volume changes.

Main Results:

  • Hyperoxia induced oxidative stress and reduced oligodendrocyte precursor cells and mature oligodendrocytes in the cerebellum.
  • Hyperoxia led to hypomyelination, thinner myelin sheaths, and reduced cerebellar volumes, indicating long-term injury.
  • Minocycline treatment prevented oxidative stress, protected oligodendrocytes, and improved levels of platelet-derived growth factor-A (PDGF-A) in astrocytes.

Conclusions:

  • Neonatal hyperoxia causes significant white matter damage and hypomyelination in the cerebellum, involving astroglial dysfunction.
  • Reduced astroglial growth factor production contributes to oligodendrocyte injury, rather than microglial inflammation.
  • Minocycline effectively prevents hyperoxia-induced cerebellar injury and rescues oligodendrocyte development, suggesting therapeutic potential.

Related Concept Videos